دورية أكاديمية
ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma: 2022 Update.
| العنوان: | ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma: 2022 Update. |
|---|---|
| المؤلفون: | Ganeshan D; The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: dganeshan@mdanderson.org., Khatri G; Panel Chair, UT Southwestern Medical Center, Dallas, Texas., Ali N; The University of Texas MD Anderson Cancer Center, Houston, Texas, Primary care physician., Avery R; Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Commission on Nuclear Medicine and Molecular Imaging., Caserta MP; Mayo Clinic, Jacksonville, Florida., Chang SD; University of British Columbia, Vancouver, British Columbia, Canada., De Leon AD; The University of Texas MD Anderson Cancer Center, Houston, Texas., Gupta RT; Duke University Medical Center, Durham, North Carolina., Lyshchik A; Thomas Jefferson University Hospital, Philadelphia, Pennsylvania., Michalski J; Mallinckrodt Institute of Radiology Washington University School of Medicine, Saint Louis, Missouri; Commission on Radiation Oncology., Nicola R; SUNY Upstate Medical University, Syracuse, New York., Pierorazio PM; Presbyterian Medical Center, University of Pennsylvania, Philadelphia, Pennsylvania; American Urological Association., Purysko AS; Cleveland Clinic, Cleveland, Ohio., Smith AD; University of Alabama at Birmingham, Birmingham, Alabama., Taffel MT; New York University Langone Medical Center, New York, New York., Nikolaidis P; Specialty Chair, Northwestern University, Chicago, Illinois. |
| مؤلفون مشاركون: | Expert Panel on Urological Imaging |
| المصدر: | Journal of the American College of Radiology : JACR [J Am Coll Radiol] 2023 May; Vol. 20 (5S), pp. S246-S264. |
| نوع المنشور: | Practice Guideline; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: United States NLM ID: 101190326 Publication Model: Print Cited Medium: Internet ISSN: 1558-349X (Electronic) Linking ISSN: 15461440 NLM ISO Abbreviation: J Am Coll Radiol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: New York, NY : Elsevier, c2004- |
| مواضيع طبية MeSH: | Carcinoma, Renal Cell*/diagnostic imaging , Carcinoma, Renal Cell*/pathology , Kidney Neoplasms*/diagnostic imaging , Kidney Neoplasms*/pathology, Humans ; United States ; Magnetic Resonance Imaging ; Societies, Medical |
| مستخلص: | Renal cell carcinoma is a complex group of highly heterogenous renal tumors demonstrating variable biological behavior. Pretreatment imaging of renal cell carcinoma involves accurate assessment of the primary tumor, presence of nodal, and distant metastases. CT and MRI are the key imaging modalities used in the staging of renal cell carcinoma. Important imaging features that impact treatment include tumor extension into renal sinus and perinephric fat, involvement of pelvicalyceal system, infiltration into adrenal gland, involvement of renal vein and inferior vena cava, as well as the presence of metastatic adenopathy and distant metastases. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation. (Copyright © 2023 American College of Radiology. Published by Elsevier Inc. All rights reserved.) |
| فهرسة مساهمة: | Keywords: AUC; Appropriate Use Criteria; Appropriateness Criteria; CT; MRI; Nephrectomy; Renal cell carcinoma |
| تواريخ الأحداث: | Date Created: 20230526 Date Completed: 20230529 Latest Revision: 20231129 |
| رمز التحديث: | 20231130 |
| DOI: | 10.1016/j.jacr.2023.02.008 |
| PMID: | 37236747 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1558-349X |
|---|---|
| DOI: | 10.1016/j.jacr.2023.02.008 |